Cullen Capital Management, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cullen Capital Management, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$276,530,464
-2.0%
2,714,809
-2.9%
3.23%
+28.1%
Q2 2023$282,133,262
-11.4%
2,795,890
-19.2%
2.52%
-13.5%
Q1 2023$318,320,239
+25.9%
3,460,003
+24.1%
2.91%
-10.2%
Q4 2022$252,867,688
-4.1%
2,787,713
-19.6%
3.24%
+14.9%
Q3 2022$263,547,000
-7.3%
3,467,273
+3.1%
2.82%
-1.1%
Q2 2022$284,302,000
-1.7%
3,363,332
+2.1%
2.86%
+7.3%
Q1 2022$289,160,000
+18.0%
3,295,271
+17.6%
2.66%
+15.8%
Q4 2021$245,146,000
-0.0%
2,802,628
-6.5%
2.30%
-4.6%
Q3 2021$245,229,000
-6.3%
2,998,638
+4.6%
2.41%
-4.7%
Q2 2021$261,639,000
+18.1%
2,867,587
+10.6%
2.53%
+5.6%
Q1 2021$221,621,000
+347.0%
2,592,668
+393.8%
2.40%
-13.0%
Q4 2020$49,578,000
-11.6%
525,026
-18.6%
2.75%
-15.2%
Q3 2020$56,084,000
-1.0%
644,935
-0.6%
3.25%
+1.9%
Q2 2020$56,649,000
-10.3%
648,600
-15.3%
3.19%
-12.5%
Q1 2020$63,125,000
-18.4%
765,620
-6.2%
3.64%
+20.1%
Q4 2019$77,330,000
+3.3%
816,660
-5.2%
3.03%
+0.9%
Q3 2019$74,875,000
-5.4%
861,626
-0.6%
3.00%
-2.7%
Q2 2019$79,135,000
-5.6%
866,666
-0.6%
3.09%
-6.6%
Q1 2019$83,851,000
+13.0%
872,176
+0.9%
3.31%
+3.4%
Q4 2018$74,196,000
-3.3%
864,651
-2.9%
3.20%
+13.2%
Q3 2018$76,696,000
+13.3%
890,156
-0.7%
2.83%
+10.3%
Q2 2018$67,703,000
-6.3%
896,251
+0.3%
2.56%
+0.2%
Q1 2018$72,227,000
-1.9%
893,351
+1.9%
2.56%
+1.2%
Q4 2017$73,641,000
-1.8%
877,096
+0.4%
2.53%
-3.3%
Q3 2017$75,026,000
+1.2%
873,916
-1.6%
2.61%
+0.3%
Q2 2017$74,121,000
+26.8%
887,991
+12.8%
2.61%
+26.8%
Q1 2017$58,468,000
-0.3%
787,235
-2.2%
2.06%
+1.6%
Q4 2016$58,628,000
+521.5%
804,890
+573.7%
2.02%
+533.9%
Q3 2016$9,434,000
+2.5%
119,480
+7.1%
0.32%
-1.5%
Q2 2016$9,205,000
+10.3%
111,560
-3.1%
0.32%
+9.8%
Q1 2016$8,344,000
-14.6%
115,180
+1.4%
0.30%
-10.6%
Q4 2015$9,773,000
-6.3%
113,585
+0.1%
0.33%
-9.8%
Q3 2015$10,431,000
-13.2%
113,475
-7.1%
0.37%
-4.7%
Q2 2015$12,017,000
-13.3%
122,200
-13.0%
0.38%
-1.0%
Q1 2015$13,855,000
-8.0%
140,500
-13.6%
0.39%
-5.1%
Q4 2014$15,067,000
-8.4%
162,600
-6.9%
0.41%
-9.3%
Q3 2014$16,445,000
+3.8%
174,700
-0.2%
0.45%
+9.7%
Q2 2014$15,843,000
-3.2%
175,000
-9.1%
0.41%
-7.2%
Q1 2014$16,362,000
+31.4%
192,450
+24.2%
0.44%
+35.5%
Q4 2013$12,451,000
+5.6%
154,900
+0.8%
0.33%
-2.1%
Q3 2013$11,786,000
+8.8%
153,650
+0.3%
0.33%
+1.5%
Q2 2013$10,832,000153,1900.33%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders